Global Microfluidic Technology Market Growth (Status and Outlook) 2023-2029

Global Microfluidic Technology Market Growth (Status and Outlook) 2023-2029

The global Microfluidic Technology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Microfluidic Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Microfluidic Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Microfluidic Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Microfluidic Technology players cover Agilent, Fluidigm Corporation, Micralyne, Inc, bioMérieux, Inc., Roche Holdings, Inc., Becton Dickinson, Danaher, PerkinElmer and Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Microfluidic Technology Industry Forecast” looks at past sales and reviews total world Microfluidic Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected Microfluidic Technology sales for 2023 through 2029. With Microfluidic Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microfluidic Technology industry.

This Insight Report provides a comprehensive analysis of the global Microfluidic Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microfluidic Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microfluidic Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microfluidic Technology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microfluidic Technology.

This report presents a comprehensive overview, market shares, and growth opportunities of Microfluidic Technology market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Digital Microfluidics
Capillary Force Driven Microfluidics
Pressure Push Microfluidics
Centrifugal Push Microfluidics
Other

Segmentation by application
Biochemical Analysis
Protein Analysis
Cell Biology
Molecular Diagnosis
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent
Fluidigm Corporation
Micralyne, Inc
bioMérieux, Inc.
Roche Holdings, Inc.
Becton Dickinson
Danaher
PerkinElmer
Bio-Rad Laboratories
Dolomite
908 Devices
MicroLIQUID
MicruX Technologies
Micronit
Fluigent
Micropoint Biotechnologies,Co.,Ltd.
Beijing Bohui Innovation Biotechnology Group Co.,ltd.
Rongzhi Biotechnology(Qingdao) Co., Ltd.
Oxford Nanopore Technologies

Please note: The report will take approximately 2 business days to prepare and deliver.